Women’s Health Innovation Program
Rethinking healthcare innovation through the lens of a woman’s body
Upstart Impacts’ Women’s Health Innovation Program helps promising early-stage life sciences and MedTech companies advance their technologies toward market while uncovering opportunities to better address women’s health needs across all areas of medicine. Our first cohort begins in February 2027.
Why Women’s Health Matters
For too long, medical research and product development have treated the male body as the default. Yet women can experience diseases differently, respond differently to treatments, and face different challenges in diagnosis and care.
Women are 50% more likely to be misdiagnosed after a heart attack, and only about 5% of healthcare R&D funding is dedicated to women’s health.
Women’s health is not just reproductive health. It includes cardiovascular disease, cancer, autoimmune and neurological conditions, metabolic disorders, and every area of medicine where women’s biology and healthcare experiences matter.
Closing this gap is both a healthcare necessity and an enormous opportunity for innovation.

A Different Approach to Women’s Health Innovation
Improving women’s health isn’t only about developing new technologies specifically for women. It’s also about looking at existing healthcare innovations differently.
Our program supports both early-stage companies already developing solutions for women’s health and other Life Sciences and MedTech companies, challenging them to examine their technologies through the lens of a woman’s body. That examination could reveal overlooked patient needs, new clinical applications, opportunities for product development, or entirely new markets.
We help companies act on these opportunities, overcome commercialization challenges, and move their innovations closer to patients.
What the Program Provides
Selected companies receive individualized support from experienced mentors, clinicians, investors, and industry experts on the challenges most important to their businesses, including IP, regulatory strategy, clinical development, reimbursement, commercialization, and fundraising. The program builds on Upstart Impacts’ proven experience supporting early-stage life sciences companies. In our 2025 Philadelphia-based program, 8 of 10 companies secured funding.
Founding partners include Ben Franklin Technology Partners and Life Sciences Greenhouse Investments, with Lewis Katz School of Medicine serving as a clinical partner.
Help Us Bring Better Healthcare to Women
Our program is offered at no cost to participating companies, thanks to the support of foundations, corporate partners, and individual donors.
Your contribution helps promising healthcare companies access the expertise, mentorship, and connections they need to bring better solutions to women, and helps build Pennsylvania as a hub for women’s health innovation.

